--- /home/parlparse/parldata/cmpages/wrans/answers2007-02-21a.html	2007-02-23 08:46:12.803969757 +0000
+++ /home/parlparse/parldata/tmp/patchtmp-answers2007-02-21a-v7LFOr.html	2007-02-23 09:13:17.788014527 +0000
@@ -671,7 +671,7 @@
 <a name="qn_31"><a name="70221w0002.htm_wqn16">
 <p><a name="07022231000411">10. <a name="07022231002715"><b>Mr. Havard:</b> To ask the Secretary of State for Wales what assessment he has made of the economic impact of Ministry of Defence expenditure in St. Athan on the Welsh economy. [121350]</p>
 
-<p><a name="st_142"><a name="07022231000412"><a name="70221w0002.htm_spnew16"><a name="07022231002716"><b>Mr. Hain:</b> : Locating the Ministry of Defence&#146;s Defence Training Academy to St. Athan will bring huge economic benefits including investment, creating jobs, regeneration and training to South Wales.</p>
+<p><a name="st_142"><a name="07022231000412"><a name="70221w0002.htm_spnew16"><a name="07022231002716"><b>Mr. Hain:</b> Locating the Ministry of Defence&#146;s Defence Training Academy to St. Athan will bring huge economic benefits including investment, creating jobs, regeneration and training to South Wales.</p>
 
 
 <page url="http://www.publications.parliament.uk/pa/cm200607/cmhansrd/cm070221/text/70221w0003.htm"/>
@@ -9564,7 +9564,7 @@
 <a name="qn_229"><a name="70221w0024.htm_wqn0">
 <p><a name="07022236001838"><a name="07022236002642"><b>Dr. Iddon:</b> To ask the Secretary of State for Health (1) what steps she is taking to ensure that medical professionals are incentivised to report under the yellow card scheme adverse drug reactions following the use of a biomedicine or a biosimilar medicine; [117202]</p>
 <a name="qnpa_22">
-<p><a name="07022236001839">To ask the Secretary of State for Health (2) what discussions she has had with the European Medicines Agency on the development of guidelines for the approval of biosimilar medicines for marketing; [117203]</p>
+<p><a name="07022236001839">(2) what discussions she has had with the European Medicines Agency on the development of guidelines for the approval of biosimilar medicines for marketing; [117203]</p>
 <a name="qnpa_23">
 <p><a name="07022236001840">(3) when she expects the European Medicines Agency to finalise guidelines for biosimilar medicines; [117204]</p>
 <a name="qnpa_24">
@@ -10099,7 +10099,7 @@
 </ul><a name="70221w0026.htm_brev2"><a name="07022236002460"><ul><p class="tabletext">the development of draft information which takes into account professional appearance, patient confidence and healthcare associated infections. This will be finalised once the final report on laundry temperatures is available; and</p>
 </ul><a name="70221w0026.htm_brev3"><a name="07022236002461"><ul><p class="tabletext">a sub-group has been formed and has commenced work to refresh HSG 95(18) &#145;Hospital laundry arrangements for used and infected linen&#146;.</p>
 </ul><a name="qn_249"><a name="70221w0026.htm_wqn3">
-<p><a name="07022236002053"><a name="07022236002682"><b>Mrs. Dorries:</b> what progress has been made in the review of policy on the uniforms of medical staff in NHS hospitals to prevent healthcare associated infections; and if she will make a statement. [118352]</p>
+<p><a name="07022236002053"><a name="07022236002682"><b>Mrs. Dorries:</b> To ask the secretary of state of Health what progress has been made in the review of policy on the uniforms of medical staff in NHS hospitals to prevent healthcare associated infections; and if she will make a statement. [118352]</p>
 
 <p><a name="st_360"><a name="07022236002054"><a name="70221w0026.htm_spnew3"><a name="07022236002683"><b>Mr. Ivan Lewis:</b> The uniform and laundry review working group was established on the 25 July 2005, with its first meeting held on that day.</p>
 
